Today's FDA approval of tavapadon makes it the first selective D1/D5 receptor agonist for the treatment of adults with Parkinson's disease.
Parkinson’s disease is a brain disorder that gradually affects movement and many other body functions. It develops as nerve ...
Project Nightfall on MSN
The guitarist who invented that sound says his hands are changing, and the tour is still on
If you have ever heard the opening of Holiday in Cambodia, you have heard a guitar doing something that almost nobody else in punk was doing. There is a single note, and then the same note again a ...
Research that won the 10th Bioindustry AwardOn July 15, 2026, Sumitomo Pharma Co., Ltd. and RACTHERA Inc. announced that the ...
Not a question of "which is superior," but differences in qualifications, roles, target conditions, insurance systems, and ...
Coya Therapeutics hits its 100th ALS trial enrollment and publishes new preclinical data, both pointing to the same ...
Discussion of Phase 2 data on bezisterim in Long COVID and Parkinson's with focus on inflammation targets September 23, 2026 11:00 ...
AC Immune maintains a "Buy" rating, driven by positive 100-week safety and immunogenicity data for ACI-7104. Click to read in ...
Imprisoned in Russia for nearly 500 days, Wall Street Journal writer Evan Gershkovich never stopped reporting. His remarkably vivid prison memoir offers an unparalleled view of Russia, its people and ...
Gold Logie winner Sonia Kruger said she’s looking seriously at her own life after seeing close family members diagnosed with ...
Explore how brain-computer interfaces are helping people with paralysis control digital devices, communicate and operate ...
Pfizer PFE and AbbVie ABBV are two major U.S. drugmakers with diversified portfolios spanning several key therapeutic areas.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results